[Hepatic angiosarcoma developed 5 years following treatment for subacute glomerulonephritis].
A patient with hepatic angiosarcoma is described. This tumour, thought rare, still generates clinical interest, because of its characteristic association with occupational exposure to certain chemicals such as vinyl chloride and thorotrast. That association has led to extensive screening of high risk populations. An additional case of liver angiosarcoma which probably developed following long-term treatment with cyclophosphamide. The significant aspects of this tumour are delineated and the diagnostic modalities are discussed.
Takkal
M
M
Cliniques Universitaires Saint-Luc Service de Chirurgie de l'Appareil Digestif, Bruxelles.
Kestens
P J
PJ
Noël
H
H
Delos
M
M
Haot
J
J
D003520:Cyclophosphamide / Q000009:adverse effects* / Q000627:therapeutic use; D003952:Diagnostic Imaging; D005921:Glomerulonephritis / Q000188:drug therapy*; D006394:Hemangiosarcoma / Q000139:chemically induced* / Q000175:diagnosis / Q000473:pathology; D006801:Humans; D008113:Liver Neoplasms / Q000139:chemically induced* / Q000175:diagnosis / Q000473:pathology; D008297:Male; D008875:Middle Aged
D003520:Cyclophosphamide
Angiosarcome hépatique développé cinq ans après traitement pour glomérulonéphrite subaiguë.